0001723420-18-000003.txt : 20180711 0001723420-18-000003.hdr.sgml : 20180711 20180711164847 ACCESSION NUMBER: 0001723420-18-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180710 FILED AS OF DATE: 20180711 DATE AS OF CHANGE: 20180711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moscato Robert Jr. CENTRAL INDEX KEY: 0001723420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 18949052 MAIL ADDRESS: STREET 1: 400 PRATT STREET STREET 2: SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marina Biotech, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17870 CASTLETON STREET STREET 2: SUITE 250 CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 BUSINESS PHONE: 4259083600 MAIL ADDRESS: STREET 1: 17870 CASTLETON STREET STREET 2: SUITE 250 CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-07-10 0 0000737207 Marina Biotech, Inc. MRNA 0001723420 Moscato Robert Jr. C/O MARINA BIOTECH, INC. 17870 CASTLETON STREET, SUITE 250 CITY OF INDUSTRY CA 91748 1 1 0 0 Chief Executive Officer Options to purchase common stock 0.66 2018-07-10 4 A 0 1500000 0 A 2028-07-10 common stock 1500000 1500000 D Options to purchase 250,000 shares of common stock are exercisable immediately, options to purchase 250,000 shares of common stock are exercisable on each of July 10, 2019, July 10, 2020 and July 10, 2021, options to purchase 250,000 shares of common stock shall vest on such date (if any) that the Issuer determines that the reporting person has earned the "2018 Revenue Bonus" (as defined in the Employment Agreement dated June 18, 2018 between the Issuer and the reporting person (the "Employment Agreement")), and options to purchase 250,000 shares of common stock shall vest on such date (if any) that the Issuer determines that the reporting person has earned the "2018 Stock Price Bonus" (as defined in the Employment Agreement). /s/ Robert C. Moscato, Jr. 2018-07-11